Current Headlines

  1. Rockwell Automation And Industry Leaders Launch The Digital CMC Consortium To Accelerate Digital Transformation In Pharmaceutical Development 10/8/2026

    Rockwell Automation, Inc. (NYSE: ROK), the world's largest company dedicated to industrial automation and digital transformation, today announced it is a founding member of the Digital CMC Consortium, a not-for-profit, pre-competitive industry collaboration focused on advancing digital standards and infrastructure to accelerate drug development.

  2. Ritedose Opens Advanced Laboratory And Expands Analytical Capabilities To Accelerate Pharmaceutical Innovation—Positioning The Company As A Preferred Partner For Drug Development And Manufacturing 10/8/2026

    The Ritedose Corporation announced the opening of its new state-of-the-art current Good Manufacturing Practice (cGMP) laboratory, marking a major milestone in the Company's continued growth and reinforcing its position as a pharmaceutical manufacturing and life sciences innovation leader.

  3. ITOCHU Announces Strengthening Of Drug Development Support Through The Use Of AI-Driven Drug Discovery Technologies 10/7/2026

    ITOCHU Corporation (headquartered in Minato-ku, Tokyo; Keita Ishii, President & COO; hereinafter “ITOCHU”) announced today that it has signed a capital alliance agreement with MOLCURE Inc. (headquartered in Kawasaki City, Kanagawa Prefecture; Satoshi Tamaki, Representative Director, CEO & CSO; hereinafter “MOLCURE”), which possesses AI-driven drug discovery technologies for antibodies and peptides.

  4. Carterra Advances Lab-In-The-Loop Drug Discovery Through New Scientific Collaboration 10/7/2026

    Carterra, a leading provider of high-throughput surface plasmon resonance (HT-SPR) platforms for antibody and small molecule drug discovery, today announced a research collaboration with AstraZeneca to develop hardware and software aimed at advancing lab-in-the loop drug discovery

  5. Nexentis: MitoCareX Bio Deploys Its Computational Drug Discovery Infrastructure On Google Cloud 10/7/2026

    Nexentis Technologies Inc. (“Nexentis”), (NASDAQ: NXTS) (“Nexentis” or the “Company”), today announced that MitoCareX Bio Ltd. (“MitoCareX”), its wholly owned subsidiary, now deploys its Computational Drug Discovery Infrastructure on Google Cloud Platform (“GCP”).

  6. Emerging Biotechs Standardize On Veeva Basics To Accelerate Drug Development 10/7/2026

    Veeva Systems (NYSE: VEEV) today announced that more than 175 emerging biotechs are establishing a technology foundation with Veeva Basics. Biotechs are launching pre-configured and pre-validated Veeva Basics applications in weeks, adding systems that can scale as they move from startup to commercialization.

  7. QIAGEN Expands AI-Powered Bioinformatics For Research And Drug Discovery 10/6/2026

    QIAGEN N.V. today announced new artificial intelligence (AI) capabilities to help researchers analyze complex biological and genomic data faster while keeping the scientific evidence behind the results visible.

  8. Thermo Fisher Scientific Showcases New Solutions And Expanded Capabilities To Accelerate Drug Development At CPHI Milan 2026 10/6/2026

    Thermo Fisher Scientific, the world leader in serving science, is expanding its drug development, manufacturing, and clinical capabilities to help pharmaceutical and biotechnology companies navigate increasingly complex paths to commercialization, reduce friction, and maintain momentum.

  9. Mitsui Chemicals Launches InnoCell P-Type High Oxygen-Permeable Culture Plates To Accelerate Organoid-Based Drug Discovery 10/5/2026

    Mitsui Chemicals, Inc. (Tokyo; President & CEO: Satoshi Ichimura) has launched InnoCell P-Type, a new adherent cell culture plate in its InnoCell series of cell culture ware, as of October 1, 2026

  10. Improving Vaccine Research Workflows Using Dependable Liquid Handling 10/2/2026

    The Wagner group at the University of Regensburg’s Institute of Medical Microbiology and Hygiene relies on liquid handling solutions from INTEGRA Biosciences to aid its vital research into molecular virology and vaccine development.